| ipilimumab alone | avelumab based treatment | nivolumab based treatment | pembrolizumab based treatment |
| Ipilimumab (10 mg/kg) | avelumab alone | nivolumab alone | nivolumab plus SoC | pembrolizumab alone | pembrolizumab plus SoC |
Comparator:
vs Standard of Care (SoC); vs placebo plus SoC; vs placebo; vs paclitaxel;
Risk of bias:
low;
some concerns;
high;
NA;